Edinburgh Research and Innovation: Licensing opportunities in Therapeutics
 

Support for University staff

link to ERI's internal website for research and commercialisation services (available to University of Edinburgh staff only)

Licensing opportunities in Therapeutics

The following technologies are available to license in Therapeutics at the University of Edinburgh.

Biopolymer coatings for improved endothelial progenitor cell growth in 2D and 3D

Biopolymer coatings for improved endothelial progenitor cell growth in 2D and 3DNew biopolymer coatings to support human endothelial cell growth and the endothelialisation of intra-vascular stents or vascular conduits potentially minimising these problems... more info >

Cattle vaccine delivery system

herd of cows at RoslinThis flexible protein delivery system for vaccinating cattle against pathogens and cattle-borne zoonoses provides long term immune protection without adverse consequences on productivity or health... more info >

Glioma-derived neuronal stem cell lines

Glioma-derived neuronal stem cell linesA new simple, efficient and reproducible method to produce glioma neural stem (GNS) cell lines from tumours, which retain the characteristics of the original tumour, can be differentiated into various neural cell types and are suitable for chemical and genetic screening... more info >

Novel polymers to derive improved hepatocytes from ES cells and iPS cells

Novel polymers to derive improved hepatocytes from ES cells and iPS cellsThis novel synthetic polymer matrix overcomes current issues of stability and viability. A defined supporting basement matrix is provided that significantly improves the morphology, lifespan and function of hepatocytes derived from human embryonic stem cells (hESCs) or induced pluripotent cells (iPSC)... more info >

Peptide-based therapy of influenza virus infection

Peptide-based therapy of influenza virus infectionA new generation of small peptides (6-12mers) has been developed with potent in vitro and in vivo activity against influenza A viruses. The peptides are capable of preventing and potentially treating influenza infection in vivo... more info >

Recombinant malaria vaccine

Recombinant malaria vaccineThis synthetic vaccine incorporates the highly variable repeat sequences of the merozoite surface protein antigen from Plasmodium falciparum, expressed during the invasive blood-stage, into one “super-antigen” sequence for use as a malaria vaccine... more info >

Research resources for development of malaria diagnostics, drugs and vaccines

Research resources for development of malaria diagnostics, drugs and vaccinesA unique collection of malaria research materials and reagents that will help researchers understand Malaria and develop new diagnostic and therapeutic approaches to tackling the disease... more info >

Synthetic antigens for vaccine development against visceral leishmaniasis

Synthetic antigens for vaccine development against visceral leishmaniasisA new vaccine approach to treating visceral leishmaniasis, which expands host protective CD8+ responses, making the host produce beneficial T cells that reduce parasite burden and alleviate disease symptoms more quickly... more info >

Therapeutic compounds for preventing and treating bacterial infections

Therapeutic compounds for preventing and treating bacterial infectionsA non-toxic cell penetrating peptide mimetic with potent antimicrobial activity against clinically important multi-drug resistant human pathogens has been designed and evaluated. This novel anti-infective has particular utility for the treatment of intracellular infections and clearance of non-replicating bacteria impervious to currently available therapeutic regimes... more info >

Latest Opportunity

Diagnostic aid to improve the early identification of skin cancerDiagnostic aid to improve the early identification of skin cancer

DERMOFIT is a diagnostic aid software that helps to correctly identify skin lesion types, leading to more effective diagnosis of skin cancer cases.

view more licensing opportunities...